Extended-Release Tacrolimus Following Liver Transplantation (NCT05242315)
Feasibility, Efficacy And Safety Of De Novo Extended-Release Tacrolimus Following Liver Transplantation
🩺 Plain-English Summary (8th-Grade Level)
Medications used after transplant to prevent rejection are associated with many side effects. Tacrolimus side effects include kidney dysfunction; tremor, headaches, difficulty sleeping, change in sensation (legs), seizure, or confusion; high blood pressure; anemia, or low blood cell counts; diabetes; abnormal cholesterol and weight gain. The investigators want to use a new, approved, formulation of the standard medication (Envarsus) as they believe it may be associated with reduced side effects. The investigators would like to assess how safe it is to use this medication and how well it works in comparison to currently used formulations. The investigators will study if there are less side effects and will study clinical outcomes (including how well the liver does and if there is need for hospitalizations after transplant). The investigators hope that this information will improve the care provided to and outcomes in patients following liver transplant.
Who can join: Review the eligibility criteria below.
Location: Univerity of Alberta — Edmonton, Alberta
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Univerity of Alberta — Edmonton, Alberta
📞 Contact the Study Coordinator
Phone: (780) 492-2235
Email: rbhanji@ualberta.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Liver Transplant; Complications
- Angiotensin II in Liver Transplantation — San Francisco, California
- Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant — Miami, Florida
- Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications — Rochester, Minnesota
- HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients — San Francisco, California
Explore by condition: All Liver Transplant; Complications clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.